… into tablets at amorphous solid dispersion loadings up to 89 wt… amorphous dispersion during
drying by TFE. Pharmacokinetic performance of the TFE-isolated, co-precipitated dispersion …

… the solid dispersion may stabilise the amorphous form, … between excipients and the
amorphous dispersion. In addition, … on the way to a coated solid dosage form, are all known risk …

… as a solid amorphous dispersion utilizing HME technology. … that reduced the number of
dosage units and eliminated the … solid oral dosage form based on amorphous solid dispersion …

… the thermodynamic behavior of amorphous SDs that have not … used in polymeric amorphous
solid dispersion systems (PASDs) … release pattern from the dosage form since the improper …

… drugs into an amorphous solid dispersion (ASD) … amorphous forms are thermodynamically
unstable, the materials and technologies that enable ASD formation, the subsequent dosage …

… factor of the formulation), a dispersed amorphous API with a 100 mg dose and a drug
content of 20% suggests that only the mass of the dispersion is 500 mg. The literature suggests …

… for generating amorphous solid dispersions have been well … However, the amorphous solid
dispersions manufactured by … those properties of amorphous solid dispersions. For example, …

… Importantly, this approach appears to offer another route to further increase the drug load
in final dosage units and is significant as increased drug loading generally results in slower or …

… to be processed into tablet or capsule dosage form. The biggest task of a solid dispersion is
to maintain the drug in the amorphous state in the final dosage form. This can be attained by …

… originates amorphous solid dispersions and uses polymeric carriers. The third generation
comprises amorphous solid dispersion composed by a combination of amorphous carriers …